Element Biosciences Bolsters Leadership Team to Advance Development and Commercialization of DNA Sequencing Platform
Element Biosciences Closes $276 Million Series C Financing to Democratize Access to Genomics
Element Biosciences Appoints Chief Commercial Officer, General Counsel, and VP of Operations
Element Raises $30M in Additional Series B Financing to Accelerate Development of a New Sequencing Platform
Element Biosciences Raises $80M in Series B Financing to Accelerate Development of a New DNA Sequencing Platform
Element Biosciences Moves to Alexandria GradLabs in Anticipation of Growth and Expansion
